Home LiteratureArticle Details
PMID: 122995 Published · ppublish English Clinical Trial Comparative Study Journal Article

Potency of fragmented IgG: two studies of postexposure prophylaxis in type A hepatitis.

The Journal of laboratory and clinical medicine ·Vol. 85 ·No. 2 ·1975-02-00 ·Pages 281-6

Brachott D, Lifschitz I, Mosley JW, Kendrick MA, Sgouris JT

Abstract

To determine the effect of fragmentation on potency of immune globulin preparations, two comparisons were carried out. In one study, the immune globulin was derived from American plasma; in the other, the source was Israeli plasma. In each of the two studies, three materials were given to household contacts of icteric hepatitis: (1) human albumin as a placebo; (2) immune globulin with the IgG intact; and (3) immune globulin of the same lot with the IgG deliberately fragmented by added fibrinolysin. Comparable reductions in secondary attack rates were achieved with fragmented and unfragmented materials from both lots. Fragmentation, therefore, had no deleterious effect. In addition, it was found that American globulin is comparable to Israeli globulin for protection against strains of Type A hepatitis prevalent in Israel. Administration in the second half (last 15 days) of the incubation period did not reduce the frequency of icteric disease.

MeSH Terms
Child Clinical Trials as Topic Female Fibrinolysin/pharmacology Hepatitis A/epidemiology,prevention & control Humans Immunoglobulin Fragments Immunoglobulin G Immunotherapy Israel Jaundice/epidemiology,prevention & control Male Michigan Placebos Serum Albumin/therapeutic use Time Factors
Chemicals
Immunoglobulin Fragments Immunoglobulin G Placebos Serum Albumin Fibrinolysin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Brachott D
Lifschitz I
Mosley J W
Kendrick M A
Sgouris J T
Article Info
Journal
The Journal of laboratory and clinical medicine
Abbr.
J Lab Clin Med
ISSN
0022-2143
Published
1975-02-00
Pages
281-6
Language
English
Region
United States
NLM ID
0375375
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com